APEX1 and metabolic dysfunction-associated steatohepatitis: APE1 expression is also up-regulated during hepatic lipid accumulation in NASH patients [13], although it is still unknown whether this upregulation has a causal role in the onset of NASH or is associated to a protective function on lipid accumulation cytotoxic effect.